Antibiotic-impregnated central venous catheters in the neonatal intensive care unit-PREVAILing questions

Affiliations

¹ Discipline of Child and Adolescent Health, University of Sydney and Department of Infectious Diseases and Microbiology, The Children's Hospital at Westmead, Sydney, NSW 2145, Australia. Electronic address: ameneh.khatami@gmail.com.
² Discipline of Child and Adolescent Health, University of Sydney and Department of Infectious Diseases and Microbiology, The Children's Hospital at Westmead, Sydney, NSW 2145, Australia.

Free article

Comment

Ameneh Khatami et al. Lancet Child Adolesc Health. 2019 Jun.

Free article

. 2019 Jun;3(6):366-367.

doi: 10.1016/S2352-4642(19)30120-8. Epub 2019 Apr 27.

¹ Discipline of Child and Adolescent Health, University of Sydney and Department of Infectious Diseases and Microbiology, The Children's Hospital at Westmead, Sydney, NSW 2145, Australia. Electronic address: ameneh.khatami@gmail.com.
² Discipline of Child and Adolescent Health, University of Sydney and Department of Infectious Diseases and Microbiology, The Children's Hospital at Westmead, Sydney, NSW 2145, Australia.

No abstract available

Comment on

Antimicrobial-impregnated central venous catheters for prevention of neonatal bloodstream infection (PREVAIL): an open-label, parallel-group, pragmatic, randomised controlled trial.
Gilbert R, Brown M, Rainford N, Donohue C, Fraser C, Sinha A, Dorling J, Gray J, McGuire W, Gamble C, Oddie SJ; PREVAIL trial team. Gilbert R, et al. Lancet Child Adolesc Health. 2019 Jun;3(6):381-390. doi: 10.1016/S2352-4642(19)30114-2. Epub 2019 Apr 27. Lancet Child Adolesc Health. 2019. PMID: 31040096 Clinical Trial.